Create your single-domain antibody in 6 weeks effortlessly with our unique EVOBodies™ program.
This is our promise.
At IMMUNOCHEM we believe that you shouldn’t struggle to generate antigen-binding molecules as starting materials for your crucial research.
Through the EVOBodies™ platform, IMMUNOCHEM provides precise AI-driven antibody discovery, helping bio-pharmaceutical managers and scientists :
👉 save time
👉 reduce stress
👉 achieve the groundbreaking research results they deserve.
Today, by combining AI and biological tools, you have the power in your hand to create your tailored antibodies in only a few weeks.
Rather than waiting months for unpredictable results from traditional immunization processes.
What's even better? This method works for any antigen, including :
🎯 little or non-immunogenic
🎯 toxic for the host
🎯 highly conserved
🎯 targeting vital functions
💫 Follow our Linkedin page and let's embark on this groundbreaking adventure together.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Rue De Chastre 11, Corroy-Le-Grand,région Wallonne 1325,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.immunochem.be/
- HQ
- Corroy-le-Grand, Région wallonne
Immunochem Questions
Immunochem's website is https://www.immunochem.be/
Immunochem's LinkedIn profile is https://be.linkedin.com/company/immunochem
Immunochem has
4 employees.
View email and phone details for 4
employees at Immunochem.
Immunochem's industry is
Biotechnology Research
Immunochem's top competitors are
Iteos Therapeutics,
Afrobodies,
Famhp - Federal Agency For Medicines And Health Products,
Quantoom Biosciences,
Exothera,
Qvq Holding Bv,
Mabsolve,
Augustine Therapeutics,
Santero Therapeutics,
Kimialys.
Immunochem's categories are Biotechnology Research
Immunochem's founding year is 1998
